| Identification | Back Directory | [Name]
3,4-MDMA-d5 (hydrochloride) | [CAS]
2747917-97-9 | [Synonyms]
d,l-MDMA-D5.HCl 3,4-MDMA-d5 (hydrochloride) d,l-MDMA-D5.HCl, 1mg/ml in Methanol (as free base) d,l-MDMA-D5.HCl, 0.1mg/ml in Methanol (as free base) α-methyl-N-(methyl-d3)-1,3-benzodioxole-5-ethan-α,β-d2-amine,monohydrochloride | [Molecular Formula]
C11H11ClD5NO2 | [MOL File]
2747917-97-9.mol | [Molecular Weight]
234.734 |
| Hazard Information | Back Directory | [Description]
3,4-MDMA-d5 (hydrochloride) (CRM) (Item No. 20743) is intended for use as an internal standard for the quantification of 3,4-MDMA (Item Nos. ISO60190 | | WARNING This product is not for human or veterinary use. | [Description]
3,4-MDMA-d5 (hydrochloride) (Item No. 42148) is intended for use as an internal standard for the quantification of 3,4-MDMA (Item Nos. ISO60190 | 13971 | 34480) by GC- or LC-MS. 3,4-MDMA is categorized as an amphetamine. 3,4-MDMA has been found in tablets seized by law enforcement and has been associated with overdoses.1,2 3,4-MDMA-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [References]
[1] DAVID MICHAEL WOOD. Variability in the 3,4-methylenedioxymethamphetamine content of “ecstasy” tablets in the UK.[J]. Emergency Medicine Journal, 2011, 28 9: 764-765. DOI: 10.1136/emj.2010.092270 [2] PATIL ARMENIAN. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series.[J]. Journal of Intensive Care Medicine, 2013, 28 4: 252-258. DOI: 10.1177/0885066612445982 |
|
|